TSX/ACB (TSX/ACB)

Toronto Stock Exchange: TSX/ACB · CAD

CA$5.67

-0.14 (-2.4%)· Recorded snapshot

Market cap	372.8M
Revenue (ttm)	314.1M
Net income (ttm)	-120.1M
EPS (ttm)	-CA$2.07
Shares out	65.7M
Volume	168,244
Beta	1.42

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 314.1M
Net income (ttm): -120.1M
EPS (ttm): -CA$2.07
Market cap: 372.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-9.4

P25 n/aP50 n/aP75 n/a

ROIC-10

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSX/ACB indicators

Market & fundamental data

Available fields

194

Groups with data

Currency

CAD

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-06
Employees	1,028
Employees change	-45
Employees growth	-4.19%
Enterprise value	CAD 295.4M
Exchange	Toronto Stock Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	2013
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA05156X8504
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split date	2024-02-20
Last stock split type	Reverse
Market cap	CAD 372.8M
Next earnings date	2026-11-06
Price	CAD 5.67
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	tsx/ACB
Website	https://www.auroramj.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-36.5%
EV/Sales	0.97x
FCF / EV yield	-16.79%
FCF yield	-13.39%
Industry forward P/E	34.53x
P/B ratio	0.72x
P/S ratio	1.22x
Price / tangible book value	0.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-13.83%
EBITDA margin	-9.54%
Gross margin	44.18%
Operating margin	-13.83%
Pretax margin	-15.89%
Profit margin	-38.25%
Profit per employee	CAD -116,860
Revenue per employee	CAD 305,517
ROA	-3.72%
ROCE	-7.94%
ROE	-9.4%
ROIC	-10.01%
ROIC (5Y)	-13.9%
SBC / revenue	3.06%
Tax / revenue	0.82%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	0
Gross profit growth	-19.13%
Gross profit growth (Q)	6.25%
Gross profit growth 3Y	60.31%
Net income growth quarters	1
Net income growth years	0
Revenue growth	12.35%
Revenue growth (Q)	-8.8%
Revenue growth (QoQ)	77.71%
Revenue growth 10Y	71.35%
Revenue growth 3Y	8.13%
Revenue growth 5Y	5.07%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -23.1M
Depreciation and amortization	CAD 13.5M
EBIT	CAD -43.5M
EBITDA	CAD -30M
EPS	CAD -2.07
FCF per share	CAD -0.78
Financing cash flow	CAD 18.5M
Free cash flow	CAD -51.2M
Free cash flow minus SBC	CAD -60.8M
Gross profit	CAD 138.7M
Income taxes	CAD 2.6M
Investing cash flow	CAD -66.3M
Net borrowing	CAD -5.1M
Net cash flow	CAD -70.9M
Net income	CAD -120.1M
Operating cash flow minus SBC	CAD -37.7M
Operating income	CAD -43.5M
Revenue	CAD 314.1M
Stock-based compensation	CAD 9.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-11.5
Book value per share	CAD 8.33
Debt / equity	0.04
Goodwill	CAD 27.3M
Interest coverage	-24.32
Long-term assets	CAD 227.4M
Long-term liabilities	CAD 20.3M
Net cash (debt)	CAD 77.3M
Net cash / market cap	20.25%
Net cash growth	100.73%
Net debt / equity	-0.15
Piotroski F-Score	3
Property, plant and equipment	CAD 145.6M
Shareholders' equity	CAD 527.1M
Tangible book value	CAD 465.9M
Tangible book value per share	CAD 7.36
Total assets	CAD 620.9M
Total cash	CAD 100M
Total debt	CAD 22.7M
Total liabilities	CAD 93.7M
WACC	11.75%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.43
Current assets	CAD 393.4M
Current liabilities	CAD 73.4M
Current ratio	5.36
Inventory turnover	0.84
Net working capital	CAD 225.9M
Quick ratio	1.92
Working capital	CAD 320M
Working capital turnover	1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.77%
Shareholder yield	-3.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-97.97%
10Y return CAGR	-32.01%
10Y total return	-97.89%
150-day SMA	CAD 4.84
1D price change	-2.41%
1M price change	-2.76%
1M total return	-2.76%
1W price change	0.89%
1W total return	0.89%
1Y price change	-20.9%
1Y return CAGR	-20.91%
1Y total return	-20.9%
20-day SMA	CAD 5.85
200-day SMA	CAD 4.93
3M price change	46.49%
3M total return	46.49%
3Y price change	-9.03%
3Y return CAGR	-3.11%
3Y total return	-9.03%
50-day SMA	CAD 5.64
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 8.75
52-week high date	2025-12-18
52-week low	CAD 3.59
52-week low date	2026-07-17
5Y price change	-93.31%
5Y return CAGR	-41.78%
5Y total return	-93.31%
6M price change	17.75%
6M total return	17.75%
All-time high	CAD 1,948.81
All-time high date	2018-10-16
All-time low	CAD 3.59
All-time low date	2026-07-17
Average true range (ATR)	CAD 0.24
Average volume	329.9K
Beta (1Y)	1.62
Beta (2Y)	1.55
Beta (5Y)	1.42
Change from 52-week high	-35.2%
Change from 52-week low	57.94%
Change from all-time high	-99.71%
Change from all-time low	57.1%
Change from open	-2.07%
Day's gap	-0.34%
Dollar volume	CAD 953,943
High price	CAD 5.79
Low price	CAD 5.59
Monthly RSI	40.01
Open price	CAD 5.79
Position in 52-week range	40%
Previous close	CAD 5.81
Price vs 150-day SMA	16.46%
Price vs 20-day SMA	-3.51%
Price vs 200-day SMA	14.52%
Price vs 50-day SMA	0.05%
Relative volume	0.51
RSI	48.2
Sharpe ratio	-0.2
Sharpe ratio (3Y)	0.28
Sharpe ratio (5Y)	-0.25
Sortino ratio	-0.21
Sortino ratio (3Y)	0.61
Sortino ratio (5Y)	-0.34
Volume	168.2K
Weekly RSI	55.4
YTD price change	-2.25%
YTD total return	-2.25%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	65.3M
Shares change (QoQ)	7.49%
Shares change (YoY)	3.77%
Shares held by insiders	0.61%
Shares held by institutions	8.23%
Shares outstanding	65.7M
Short % of float	3.33%
Short % of shares	3.32%

Deeper analysis on TSX/ACB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/ACB report

Is a complete TSX/ACB research report available?

No complete published report is available for tsx/ACB (TSX/ACB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/ACB (TSX/ACB)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/ACB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/ACB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/ACB

Frequently asked questions